- Home
- RDCM vs CDTX Comparison
RDCM vs CDTX Comparison
Compare RDCM & CDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDCM
- CDTX
- Stock Information
- Founded
- RDCM 1985
- CDTX 2012
- Country
- RDCM Israel
- CDTX United States
- Employees
- RDCM 295
- CDTX N/A
- Industry
- RDCM Computer peripheral equipment
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RDCM Technology
- CDTX Health Care
- Exchange
- RDCM Nasdaq
- CDTX Nasdaq
- Market Cap
- RDCM 203.4M
- CDTX 207.4M
- IPO Year
- RDCM 1997
- CDTX 2015
- Fundamental
- Price
- RDCM $12.81
- CDTX $21.54
- Analyst Decision
- RDCM Strong Buy
- CDTX Strong Buy
- Analyst Count
- RDCM 2
- CDTX 7
- Target Price
- RDCM $15.00
- CDTX $32.20
- AVG Volume (30 Days)
- RDCM 146.7K
- CDTX 91.1K
- Earning Date
- RDCM 02-12-2025
- CDTX 11-07-2024
- Dividend Yield
- RDCM N/A
- CDTX N/A
- EPS Growth
- RDCM 79.17
- CDTX N/A
- EPS
- RDCM 0.43
- CDTX N/A
- Revenue
- RDCM $61,009,000.00
- CDTX $44,653,000.00
- Revenue This Year
- RDCM $13.44
- CDTX N/A
- Revenue Next Year
- RDCM $11.00
- CDTX N/A
- P/E Ratio
- RDCM $29.79
- CDTX N/A
- Revenue Growth
- RDCM 18.23
- CDTX 44.48
- 52 Week Low
- RDCM $8.52
- CDTX $10.00
- 52 Week High
- RDCM $15.98
- CDTX $28.42
- Technical
- Relative Strength Index (RSI)
- RDCM 45.02
- CDTX 48.34
- Support Level
- RDCM $12.58
- CDTX $20.50
- Resistance Level
- RDCM $13.88
- CDTX $24.95
- Average True Range (ATR)
- RDCM 1.04
- CDTX 1.66
- MACD
- RDCM -0.18
- CDTX 0.20
- Stochastic Oscillator
- RDCM 20.15
- CDTX 50.36
About RDCM Radcom Ltd.
Radcom Ltd Ltd is engaged in providing network intelligence, 5G ready cloud-native, network intelligence solutions for telecom operators transitioning to 5G. The company has a network intelligence solution for 5G namely Radcom ACE. Its products consist of Radcom Network Visibility, Radcom Service Assurance, and Radcom Network Insights. It has offices in Israel, the United States, Brazil, and India. Key revenue is derived from sales in North America.
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.